Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-040771
Filing Date
2010-07-30
Accepted
2010-07-30 14:31:09
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-12605_110q.htm 10-Q 815709
2 EX-31.1 a10-12605_1ex31d1.htm EX-31.1 15463
3 EX-31.2 a10-12605_1ex31d2.htm EX-31.2 16373
4 EX-32.1 a10-12605_1ex32d1.htm EX-32.1 8215
5 EX-32.2 a10-12605_1ex32d2.htm EX-32.2 8269
  Complete submission text file 0001104659-10-040771.txt   3369460

Data Files

Seq Description Document Type Size
6 EX-101.INS cvd-20100630.xml EX-101.INS 428786
7 EX-101.SCH cvd-20100630.xsd EX-101.SCH 19593
8 EX-101.CAL cvd-20100630_cal.xml EX-101.CAL 56088
9 EX-101.LAB cvd-20100630_lab.xml EX-101.LAB 242923
10 EX-101.PRE cvd-20100630_pre.xml EX-101.PRE 117172
11 EX-101.DEF cvd-20100630_def.xml EX-101.DEF 80396
Mailing Address COVANCE INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094524440
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12213 | Film No.: 10980837
SIC: 8731 Services-Commercial Physical & Biological Research